JAK2 V617F mutation analysis in different myeloid lineages (granulocytes, platelets, CFU-MK, BFU-E and CFU-GM) in essential thrombocythemia patients

Leukemia. 2006 Oct;20(10):1903-5. doi: 10.1038/sj.leu.2404341. Epub 2006 Aug 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Platelets / enzymology
  • Blood Platelets / pathology
  • Cell Lineage
  • DNA Mutational Analysis
  • Erythroid Precursor Cells
  • Granulocytes / enzymology
  • Granulocytes / pathology
  • Humans
  • Janus Kinase 2
  • Myeloid Cells / enzymology*
  • Myeloid Cells / pathology
  • Point Mutation
  • Protein-Tyrosine Kinases / genetics*
  • Proto-Oncogene Proteins / genetics*
  • Thrombocythemia, Essential / genetics*
  • Thrombocythemia, Essential / pathology
  • Thrombocythemia, Essential / physiopathology

Substances

  • Proto-Oncogene Proteins
  • Protein-Tyrosine Kinases
  • JAK2 protein, human
  • Janus Kinase 2